References

Insulin resistance in type 2 diabetes mellitus

10.1038/s41574-025-01114-y · 2025 · External reference

Metabolomics dissection of depression heterogeneity and related cardiometabolic risk

10.1017/s0033291721001471 · 2023 · External reference

Symptomatology of depression and onset of cardiometabolic diseases − a 7-year follow-up study

10.1016/j.bbi.2026.106285 · 2026 · External reference

Depression with atypical neurovegetative symptoms shares genetic predisposition with immuno-metabolic traits and alcohol consumption

10.1017/s0033291720002342 · 2022 · External reference

Quality of life among patients with cardiac disease: the impact of comorbid depression

10.1186/s12955-020-01433-w · 2020 · External reference

Gene signatures in peripheral blood immune cells related to insulin resistance and low tyrosine metabolism define a sub-type of depression with high CRP and anhedonia

10.1016/j.bbi.2020.03.015 · 2020 · External reference

10.1093/eurheartj/ehaf191

10.1093/eurheartj/ehaf191 · 2025 · External reference

Atypical depression and double depression predict new-onset cardiovascular disease in U.S. adults

10.1002/da.22666 · 2018 · External reference

International physical activity questionnaire: 12-country reliability and validity

10.1249/01.mss.0000078924.61453.fb · 2003 · External reference

Metabolomics signatures of depression: the role of symptom profiles

10.1038/s41398-023-02484-5 · 2023 · External reference

Inflammatory markers and cardiometabolic diseases

10.1179/2295333715y.0000000004 · 2015 · External reference

Inflammation effects on motivation and motor activity: role of dopamine

10.1038/npp.2016.143 · 2017 · External reference

What does plasma CRP tell us about peripheral and central inflammation in depression?

10.1038/s41380-018-0096-3 · 2020 · External reference

Association between systemic inflammation and individual symptoms of depression: a pooled analysis of 15 population-based cohort studies

10.1176/appi.ajp.2021.20121776 · 2021 · External reference

The impact of depressive disorder symptoms and subtypes on 6-year incidence of somatic diseases

10.1159/000491933 · 2018 · External reference

Melancholic and atypical subtypes of depression represent distinct pathophysiological entities: CRH, neural circuits, and the diathesis for anxiety and depression

10.1038/mp.2013.5 · 2013 · External reference

Measures of depression and risk of type 2 diabetes: a systematic review and meta-analysis

10.1016/j.jad.2020.01.053 · 2020 · External reference

Metabolic syndrome

2019 · External reference

Association of depression and cardiovascular disease

10.1016/j.amjmed.2023.04.036 · 2023 · External reference

Sociodemographic and psychiatric determinants of attrition in the Netherlands Study of Depression and Anxiety (NESDA)

10.1016/j.comppsych.2011.01.011 · 2012 · External reference

Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depression

10.1038/mp.2012.144 · 2013 · External reference

Depression profilers and immuno-metabolic dysregulation: longitudinal results from the NESDA study

10.1016/j.bbi.2020.04.002 · 2020 · External reference

Anhedonic depression, history of depression, and anxiety as gender-specific risk factors of myocardial infarction in healthy men and women: the HUNT study

10.1177/2055102914557658 · 2014 · External reference

Etiologic effects and optimal intakes of foods and nutrients for risk of cardiovascular diseases and diabetes: systematic reviews and meta-analyses from the Nutrition and Chronic Diseases Expert Group (NutriCoDE)

10.1371/journal.pone.0175149 · 2017 · External reference

Metabolic syndrome, depression and anhedonia among young adults

10.1016/j.psychres.2018.08.009 · 2019 · External reference

Depression and health-related quality of life of patients with type 2 diabetes attending tertiary level hospitals in Dhaka, Bangladesh

10.1186/s41256-023-00328-9 · 2023 · External reference

Prevalence of low-grade inflammation in depression: a systematic review and meta-analysis of CRP levels

10.1017/s0033291719001454 · 2019 · External reference

The Netherlands Study of Depression and Anxiety (NESDA): rationale, objectives and methods

10.1002/mpr.256 · 2008 · External reference

Cohort profile of the longitudinal Netherlands Study of Depression and Anxiety (NESDA) on etiology, course and consequences of depressive and anxiety disorders

10.1016/j.jad.2021.03.026 · 2021 · External reference

Depression, diabetes, comorbid depression and diabetes and risk of all-cause and cause-specific mortality: a prospective cohort study

10.1007/s00125-022-05723-4 · 2022 · External reference

Role of depression in the development of cardiometabolic multimorbidity: findings from the UK Biobank study

10.1016/j.jad.2022.09.084 · 2022 · External reference

The inventory of depressive symptomatology (IDS): preliminary findings

1986 · External reference

The inventory of depressive symptomatology (IDS): psychometric properties [Article]

10.1017/s0033291700035558 · 1996 · External reference

The Inventory of Depressive Symptomatology (IDS): clinician (IDS-C) and self-report (IDS-SR) ratings of depressive symptoms

10.1002/mpr.79 · 2000 · External reference

Predicting incident cardio-metabolic disease among persons with and without depressive and anxiety disorders: a machine learning approach

10.1007/s00127-025-02857-9 · 2025 · External reference

Trajectories of depressive symptoms, metabolic syndrome, inflammation, and cardiometabolic diseases: a longitudinal Bayesian network approach

10.1016/j.bbi.2025.106120 · 2025 · External reference

Depressive disorder subtypes, depressive symptom clusters, and risk of obesity and diabetes: a systematic review

10.1016/j.jad.2024.02.051 · 2024 · External reference

Metabolic syndrome and cardiovascular diseases: going beyond traditional risk factors

10.1002/dmrr.3502 · 2022 · External reference

Depressive symptoms decrease health-related quality of life of patients with coronary artery disease and diabetes: a 12-month follow up study in primary care

10.1080/02813432.2023.2233995 · 2023 · External reference

Cardiovascular risk indicators among depressed persons: a special case?

10.1016/j.jad.2023.02.092 · 2023 · External reference

Role of leptin in obesity, cardiovascular disease, and type 2 diabetes

10.3390/ijms25042338 · 2024 · External reference

Reliability and validity studies of the WHO-Composite International Diagnostic Interview (CIDI): a critical review

10.1016/0022-3956(94)90036-1 · 1994 · External reference

Inflammation, metabolic dysregulation, and depression profiles related to anhedonia and atypical, energy-related symptoms

10.1016/j.bbi.2025.106240 · 2026 · External reference